Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond annotations (readOnly, idempotent), description adds: data sources (SEC EDGAR/XBRL for companies, FAERS for drugs), handling of off-calendar fiscal years, sorting by primary metric, and return of paired data with citation URIs.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is dense with useful information and front-loaded with examples. Slightly verbose but every sentence contributes value. Could be tightened slightly without losing clarity.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a 2-param tool with no output schema, the description covers data sources, sorting behavior, citation URIs, and even fiscal year handling. No gaps in understanding what the tool does and returns.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema has 100% coverage, but description adds significant meaning: for type, explains what data each entity type pulls (revenue, net income, etc. for companies; adverse events, approvals, trials for drugs). For values, specifies format (tickers/CIKs for company, names for drug) and constraint (2-5 items).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description clearly states the tool does side-by-side comparison of 2-5 companies or drugs, with specific query examples like 'X vs Y' and 'rank these companies'. It distinguishes itself from siblings like entity_profile for single lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Explicitly says 'ALWAYS PREFER over sequential single-pack lookups when comparing entities', providing clear when-to-use guidance. Also states it replaces 8-15 sequential lookups, reinforcing efficiency.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A4/5.0
Disambiguation5/5

Each tool has a clear, distinct purpose with detailed descriptions that differentiate overlapping capabilities (e.g., ask_pipeworx vs deep_research vs ask_pipeworx_grounded vs bet_research). No two tools appear redundant; even similar prediction-market tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk) have specific scopes.

Naming Consistency5/5

Tool names consistently use lowercase snake_case (e.g., ai_visibility_check, compare_entities, pipeworx_trending, polymarket_kalshi_spread). Single-word exceptions (ephemeris, lookup, observers, recall, remember, vectors) are common short verbs and do not break the pattern. No mixing of camelCase or other conventions.

Tool Count4/5

35 tools is above the typical 3-15 range, but the server is a comprehensive data platform covering multiple domains (SEC, FDA, FRED, prediction markets, memory, subscriptions, feedback). The count is justified given the breadth; it feels slightly heavy but not bloated or redundant.

Completeness5/5

The tool surface covers the full lifecycle for a data/research platform: discovery (discover_tools, suggest_questions), entity resolution (resolve_entity), lookups (ask_pipeworx, entity_profile), comparison (compare_entities), validation (validate_claim), prediction-market operations (polymarket_*), memory (remember/recall/forget), subscriptions (subscribe/unsubscribe/list_subscriptions/recent_alerts), and meta/feedback (pipeworx_feedback, pipeworx_trending). No obvious gaps for typical workflows.